Cancer News Review
Prostate cancer topics abound in the latest Cancer News Review podcast. Dr. Bill Nelson, director of the Johns Hopkins Kimmel Cancer Center, discusses Hopkins-led research, published in… Read More »Cancer News Review
Prostate cancer topics abound in the latest Cancer News Review podcast. Dr. Bill Nelson, director of the Johns Hopkins Kimmel Cancer Center, discusses Hopkins-led research, published in… Read More »Cancer News Review
It's been a game-changing year in cancer research. Doctors and scientists don't typically like to use those words, but here's why I think this is a… Read More »Top Trends in Cancer Research 2011
Kimmel Cancer experts frequently say that “the best way to cure cancer is to prevent it from ever occurring.” Most experts agree that currently-available cancer… Read More »Cancer Screening Tests Everyone Should Know
Three stories top the list of major developments in cancer research during the past month. Listen to these topics discussed in the most recent Cancer News Review podcast.
First, to treat or not to treat is the question for low-risk prostate cancer. Whether to give aggressive treatments for low-risk cancer contained within the prostate is a controversy that many experts in the field still debate. Prostate cancer expert and Kimmel Cancer Center director William Nelson reviews a study analyzing how treatment decisions for these cancers are made and how quality of life expectations are communicated. He says the current problem is that screening, which has helped decrease mortality from prostate cancer, has identified some men who could live their entire lives with prostate cancer but die of other causes. He believes there are certain groups of men who should consider active surveillance programs to carefully monitor low-risk, organ-confined prostate cancer.
In this month's Cancer News Review podcast, Cancer Center director Bill Nelson reviews top headlines in cancer research. Each of the studies discussed here were published in the Oct. 2 issue of the Lancet.